NEXAVAR (sorafenib tosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+2
Bayer HealthCare
Indication
Differentiated thyroid carcinoma
Differentiated thyroid carcinoma is a malignant neoplasm originating from the follicular epithelial cells of the thyroid gland, representing the vast majority of all thyroid cancers. Read more about Differentiated thyroid carcinoma
9 drugs 9 manufacturers
Drugs that treat it
Common Differentiated thyroid carcinoma therapies.
LENVIMA (lenvatinib mesylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+3
EISAI INC.
CABOMETYX (cabozantinib s-malate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+4
EXELIXIS, INC.
SORAFENIB (sorafenib tosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+2
Mylan Pharmaceuticals
SORAFENIB (sorafenib tosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+2
TORRENT PHARMAC
SORAFENIB (sorafenib tosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+2
TEVA PHARM
SORAFENIB (sorafenib tosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+2
DR.REDDY'S LAB
SORAFENIB (sorafenib tosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+2
GSMS, INC.
SORAFENIB (sorafenib tosylate)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS·RENAL CELL CARCINOMA·+2
Allen's Cylinder
Filter & compare in the drug finder →Opens the drug finder with Differentiated thyroid carcinoma preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDifferentiated thyroid carcinoma is a malignant neoplasm originating from the follicular epithelial cells of the thyroid gland, representing the vast majority of all thyroid cancers.
It primarily encompasses papillary thyroid carcinoma and follicular thyroid carcinoma, characterized by malignant cells that largely retain histological and functional features of normal thyroid tissue, including thyroid-stimulating hormone responsiveness and the capacity for iodine uptake.
The condition predominantly affects adults, with a notable female predominance, and most commonly manifests as an asymptomatic, slow-growing neck mass or solitary thyroid nodule.
While differentiated thyroid carcinoma generally follows an indolent course with a favorable prognosis, advanced or refractory cases can exhibit local invasion into adjacent cervical structures, cervical lymph node metastasis, or hematogenous dissemination to distant sites such as the lungs and bones.
- nih.gov
Differentiated thyroid carcinoma is a malignant neoplasm originating from the follicular epithelial cells of the thyroid gland, representing the vast majority of all thyroid cancers It primarily encompasses papillary thyroid carcinoma and follicular thyroid carcinoma, characterized by malignant cells that largely retain histological and functional features of normal thyroid tissue, including thyroid-stimulating hormone responsiveness and the capacity for iodine uptake
- cancer.gov
Differentiated thyroid carcinoma is a malignant neoplasm originating from the follicular epithelial cells of the thyroid gland, representing the vast majority of all thyroid cancers It primarily encompasses papillary thyroid carcinoma and follicular thyroid carcinoma, characterized by malignant cells that largely retain histological and functional features of normal thyroid tissue, including thyroid-stimulating hormone responsiveness and the capacity for iodine uptake
- frontiersin.org
Differentiated thyroid carcinoma is a malignant neoplasm originating from the follicular epithelial cells of the thyroid gland, representing the vast majority of all thyroid cancers The condition predominantly affects adults, with a notable female predominance, and most commonly manifests as an asymptomatic, slow-growing neck mass or solitary thyroid nodule While differentiated thyroid carcinoma generally follows an indolent course with a favorable prognosis, advanced or refractory cases can exh...
- healthline.com
It primarily encompasses papillary thyroid carcinoma and follicular thyroid carcinoma, characterized by malignant cells that largely retain histological and functional features of normal thyroid tissue, including thyroid-stimulating hormone responsiveness and the capacity for iodine uptake
- nih.gov
The condition predominantly affects adults, with a notable female predominance, and most commonly manifests as an asymptomatic, slow-growing neck mass or solitary thyroid nodule
- nih.gov
The condition predominantly affects adults, with a notable female predominance, and most commonly manifests as an asymptomatic, slow-growing neck mass or solitary thyroid nodule
Personalize your experience
Follow Differentiated thyroid carcinoma and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.